Anti-seizure effects of progesterone and 3α,5α-THP in kainic acid and perforant pathway models of epilepsy

Psychoneuroendocrinology

Volumn 25, Issue 4, 2000, Pages 407-420

  Frye, Cheryl A ^a,b   Scalise, Trudy J ^b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b The Holleran Center for Community Action and Public Policy   (United States)

Author keywords

5 pregnan 3 ol 20 one (3 ,5 THP); Hippocampus; Neuroprotection; Neurosteroid; Non genomic

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; KAINIC ACID; PROGESTERONE; PROGESTERONE RECEPTOR; STEROID 5ALPHA REDUCTASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EPILEPSY; FEMALE; FOCAL EPILEPSY; HIPPOCAMPUS; NEUROPROTECTION; NONHUMAN; PERFORANT NERVE TRACT; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SEIZURE;

ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; EPILEPSY; FEMALE; KAINIC ACID; OVARIECTOMY; PERFORANT PATHWAY; PREGNANOLONE; PROGESTERONE; RATS; RATS, LONG-EVANS;

EID: 0034053837     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(99)00068-2     Document Type: Article

References (36)

1. Belelli D., Bolger M.B., Gee K.W. Anticonvulsant profile of the progesterone metabolite 5α pregnan-3α-ol-20-one. Eur. J. Pharmacol. 166:1989;325-329.
2. Belelli D., Lan N.C., Gee K.W. Anticonvulsant steroids and the GABA benzodiazepine receptor-chloride ionophore complex. Neurosci. Biobehav. Rev. 14:1990;315-322.
3. A receptor function. Pharmacol. Biochem. Behav. 45:1993;423-428.
4. A receptors. J. Neuroendocrinol. 7:1995;171-177.
5. Brinton R.D. The neurosteroid 3α-hydroxy-5α-pregnan-20-one induces cytoarchitectural regression in cultured fetal hippocampal neurons. J. Neurosci. 14:1994;2763-2774.
6. Duax W.L., Cody V., Griffin J.F., Rohrer D.C., Weeks C.M. Molecular conformation and protein binding affinity of progestins. J. Toxicol. Environ. Health. 4:1978;205-227.
7. Finn D.A., Gee K.W. The estrus cycle, sensitivity to convulsants and the anticonvulsant effect of a neuroactive steroid. J. Pharmacol. Exp. Ther. 271:1994;164-170.
8. Finn D.A., Roberts A.J., Crabbe J.C. Neuroactive steroid sensitivity in withdrawal seizure-prone and -resistant mice. Alcohol Clin. Exp. Res. 19:1995;410-415.
9. Francis J., Mihic S.J., Sneddon W.B., Burnham W.M. The effect of anticonvulsant drugs on GABA-stimulated chloride uptake. Can. J. Neurol. Sci. 21:1994;3-8.
10. Frye C.A. The neurosteroid 3α,5α-THP has anti-seizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res. 696:1995;113-120.
11. A receptor complex, attenuates pain sensitivity in rats. Brain Res. 643:1994;194-203.
12. Frye C.A., Duncan J.E. Estradiol benzoate potentiates neuroactive steroids effects on pain sensitivity. Pharmacol. Biochem. Behav. 53:1995;27-32.
13. Frye C.A., Bayon L.B. Seizure activity is increased in endocrine states characterized by decline in endogenous levels of the neurosteroid 3α,5α-THP. Neuroendocrinology. 68:1998;272-280.
14. Frye C.A., McCormick C.M., Coopersmith C., Erskine M.S. Effects of paced and non-paced mating stimulation on plasma progesterone, 3α-diol and corticosterone. Psychoneuroendocrinology. 21:1996;431-439.
15. Frye C.A., van Keuran K.R., Erskine M.S. Behavioral effects of 3α-androstanediol: I. Modulation of sexual receptivity and promotion of GABA-stimulated chloride flux. Behav. Brain Res. 79:1996;109-118.
16. Frye C.A., Bayon L.B., Pursnani N.K., Purdy R.H. The neurosteroids, progesterone and 3α,5α-THP, enhance sexual motivation, receptivity, and proceptivity in female rats. Brain Res. 808:1998;72-83.
17. Frye C.A., Scalise T.J., Bayon L.E. Finasteride blocks the reduction in ictal activity produced by exogenous estrous cyclicity. J. Neuroendocrinol. 10:1998;196-291.
18. Herzog A.G. Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology. 45:1995;1660-1662.
19. Iswari S., Colas A.E., Karavolas H.J. Binding of 5α-dihydroprogesterone and other progestins to female rat anterior pituitary nuclear extracts. Steroids. 47:1996;189-203.
20. Jacono J.J., Robertson J.M. The effects of estrogen progesterone and ionized calcium on seizures during the menstrual cycle of epileptic women. Epilepsia. 28:1987;571-577.
21. A receptor binding. Pharmacol. Biochem. Behav. 43:1992;441-447.
22. A receptor - Mechanism of action and physiological significance. Prog. Neurobiol. 38:1992;379-395.
23. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 232:1986;1004-1007.
24. Mattson R.H., Cramer J.A. Epilepsy, sex hormones, and antiepiliptic drugs. Epilepsia. 26:1985;40-51.
25. Murri L., Bonuccelli U., Melis G.B. Neuroendocrine evaluation in catamenial epilepsy. Funct. Neurol. 1:1986;399-403.
26. Patchev V.K., Shoaib M., Holsboer F., Almeida O.F.X. The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone induce anxiety and alerts the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience. 62:1994;265-271.
27. Rodbard, D., Hutt, D.M., 1974. Statistical analysis of radioimmunoassay and immunoradiometric assays: a generalized, weighted iterative, least squares method for logistic curve fitting. In: International Atomic Energy Agency (Ed.), Symposium on Radioimmunoassay and related procedures in medicine. Uniput, New York.
28. Rosciszewska D., Buntner B., Guz I., Zawisza L. Ovarian hormones, anticonvulsant drugs, and seizures during the menstrual cycle in women with epilepsy. J. Neurol. Neurosurg. Psych. 49:1986;47-51.
29. Schachter S.C. Hormonal considerations in women with seizures. Arch. Neurol. 45:1988;1267-1270.
30. A receptor-gated ion channel: biochemical and pharmacological studies of structure and function. Biochem. Pharmacol. 37:1988;3369-3375.
31. Selye H. The antagonism between anesthetic steroid hormones and pentamethylenetetrazol (metrazol). J. Lab. Clin. Med. 27:1942;1051-1053.
32. Smith H.E., Smith R.G., Toft D.O., Neegard J.R., Burrows E.P., O'Malley B.W. Binding of steroids to progesterone receptor proteins in chick oviduct and human uterus. J. Biol. Chem. 249:1974;5924-5932.
33. Smith S., Gong Q., Li X., Moran M., Bitran D., Frye C., Hsu F. Withdrawal from 3α-oh-5α-pregnan-20-one using a pseudopregnancy model alters the kinetics of hippocampal GABA-gated current and increases the Gaba receptor α4 subunit in association with increased anxiety. Neuroscience. 18:1998;5275-5284.
34. Sutula T.P. Experimental models of temporal lobe epilepsy: new insights from the study of kindling and synaptic reorganization. Epilepsia. 31:1990;s45-s54.
35. Tauboll E., Lindstrom S. The effect of progesterone and its metabolite 5α-pregnan-3α-ol-20-one on focal epileptic seizures in the cat's visual cortex in vivo. Epilep. Res. 14:1993;17-30.
36. Wilson M.A. Influences of gender, gonadectomy, and estrous cycle on GABA/BZ receptors and benzodiazepine responses in rats. Brain Res. Bull. 29:1992;165-172.